The Global Cardiac Rhythm Management Market Is Set to Expand from USD 24.7 Billion in 2024 To USD 36.7 Billion by 2034, ...

The global cardiac pacemakers market is an essential segment within the broader cardiovascular medical devices industry, ...

Traveling alone allows you to spend uninterrupted time with yourself-a rare luxury in today's fast-paced world. Without the ...

The global pacemakers market, valued at USD 4.4 billion in 2020, is anticipated to grow to USD 5.4 billion by 2027, at a CAGR of 3.0% during the forecast period (2021-2027). This growth is primarily ...

The global temporary pacing leads market is poised for significant growth, with sales estimated at USD 369.79 million in 2024 and projected to reach USD 519.56 million by 2034. This market expansion ...

report_id=Pol1267 A pacemaker is a medical device that sends brief electrical pulses to the heart’s muscles. It is a medical technology that is placed in the chest and belly to detect abnormal heart ...

Abbott has launched a pacemaker in India for the treatment of patients with slow heart rhythms. Abbott has introduced AVEIR VR single-chamber ventricular leadless pacemaker which has been approved by ...

Advt People who experience slower-than-normal heart rhythm may receive a pacemaker to deliver pulses of electricity to trigger the heart to beat properly. Balbir Singh, Chairman Cardiology ...

New Delhi, Nov 22 (PTI) Drug firm Abbott has launched a pacemaker in India for the treatment of patients with slow heart rhythms. Abbott has introduced AVEIR VR single-chamber ventricular leadless ...

Abbott, a global healthcare company, has announced the launch of AVEIR VR single-chamber ventricular leadless pacemaker for the treatment of patients in India with slow heart rhythms. This pacemaker ...

Once in place, the pacemaker continuously monitors the heart's electrical activity and delivers impulses as needed to maintain a regular rhythm ... invasive surgery and external wires but also ...